AES Trademark

Trademark Overview


On Monday, December 30, 2019, a trademark application was filed for AES with the United States Patent and Trademark Office. The USPTO has given the AES trademark a serial number of 88742108. The federal status of this trademark filing is REGISTERED as of Tuesday, August 18, 2020. This trademark is owned by Synexus Clinical Research US, Inc.. The AES trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Business management of clinical trials for others; recruitment of clinical drug trial participants, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; marketing of healthcare and pharmaceutical products of others; compiling information into computer databases, namely, collecting and compiling consumer preference information regarding health conditions, clinical trial participation interest, and clinical trial candidacy for business purposes; collection of market research information, namely, collecting and compiling clinical trial statistics and information for business purposes

Clinical research and scientific analysis in the field of pharmaceutical drugs, medical devices, and clinical trials
aes

General Information


Serial Number88742108
Word MarkAES
Filing DateMonday, December 30, 2019
Status700 - REGISTERED
Status DateTuesday, August 18, 2020
Registration Number6128809
Registration DateTuesday, August 18, 2020
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 2, 2020

Trademark Statements


Description of MarkThe mark consists of the letters "AES" in a stylized font.
Pseudo MarkACCELERATED ENROLLMENT SOLUTIONS
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesBusiness management of clinical trials for others; recruitment of clinical drug trial participants, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; marketing of healthcare and pharmaceutical products of others; compiling information into computer databases, namely, collecting and compiling consumer preference information regarding health conditions, clinical trial participation interest, and clinical trial candidacy for business purposes; collection of market research information, namely, collecting and compiling clinical trial statistics and information for business purposes
Goods and ServicesClinical research and scientific analysis in the field of pharmaceutical drugs, medical devices, and clinical trials

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, January 9, 2020
Primary Code035
First Use Anywhere DateWednesday, May 1, 2019
First Use In Commerce DateWednesday, May 1, 2019

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 9, 2020
Primary Code042
First Use Anywhere DateWednesday, May 1, 2019
First Use In Commerce DateWednesday, May 1, 2019

Trademark Owner History


Party NameSynexus Clinical Research US, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDoylestown, PA 18901

Party NameSynexus Clinical Research US, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTempe, AZ 85285

Party NameSynexus Clinical Research US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTempe, AZ 85285

Trademark Events


Event DateEvent Description
Thursday, January 2, 2020NEW APPLICATION ENTERED
Monday, March 23, 2020ASSIGNED TO EXAMINER
Wednesday, April 15, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 31, 2020NON-FINAL ACTION WRITTEN
Tuesday, March 31, 2020NON-FINAL ACTION E-MAILED
Tuesday, March 31, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 15, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 16, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 20, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 27, 2020ASSIGNED TO LIE
Wednesday, May 13, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 2, 2020PUBLISHED FOR OPPOSITION
Tuesday, June 2, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 18, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, August 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 18, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, November 23, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 23, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 23, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 23, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 23, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 18, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, August 18, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 18, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 18, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 18, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 18, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED